Conduit Pharmaceuticals Stock to Reverse Split on Monday, January 27th (NASDAQ:CDT)

Conduit Pharmaceuticals Inc. (NASDAQ:CDT) shares are set to reverse split on the morning of Monday, January 27th. The 1-100 reverse split was announced on Thursday, January 23rd. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, January 24th.

Conduit Pharmaceuticals Trading Down 20.0 %

CDT traded down $0.01 on Thursday, hitting $0.05. The company had a trading volume of 46,306,568 shares, compared to its average volume of 143,065,000. The business’s fifty day simple moving average is $0.08 and its 200 day simple moving average is $0.13. Conduit Pharmaceuticals has a 12-month low of $0.05 and a 12-month high of $3.92.

Conduit Pharmaceuticals Company Profile

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.